Notice: file_put_contents(): Write of 3972 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50

Warning: file_put_contents(): Only 4096 of 8068 bytes written, possibly out of free disk space in /var/www/tg-me/post.php on line 50
Readhub | Telegram Webview: readhub_cn/250407 -
Telegram Group & Telegram Channel
映恩生物通过港交所聆讯:已建立12条ADC管线,签订合作交易超60亿美元

映恩生物专注于研发ADC创新药物,针对癌症和自身免疫性疾病患者。公司已构建12款自主研发的ADC候选药物管线,其中包括七款处于临床阶段的ADC,两款预计于2025至2026年进入临床阶段的新一代双特异性ADC,以及多款临床前ADC。

媒体报道
映恩生物:通过港交所聆讯,即将上市 医药魔方
映恩生物通过港交所聆讯:已建立12条ADC管线 DoNews
映恩生物通过港交所聆讯:已建立12条ADC管线,签订合作交易超60亿美元 医药魔方

事件追踪
2021-05-20 映恩生物Duality Biologics完成9000万美元B轮融资

#热门话题



tg-me.com/readhub_cn/250407
Create:
Last Update:

映恩生物通过港交所聆讯:已建立12条ADC管线,签订合作交易超60亿美元

映恩生物专注于研发ADC创新药物,针对癌症和自身免疫性疾病患者。公司已构建12款自主研发的ADC候选药物管线,其中包括七款处于临床阶段的ADC,两款预计于2025至2026年进入临床阶段的新一代双特异性ADC,以及多款临床前ADC。

媒体报道
映恩生物:通过港交所聆讯,即将上市 医药魔方
映恩生物通过港交所聆讯:已建立12条ADC管线 DoNews
映恩生物通过港交所聆讯:已建立12条ADC管线,签订合作交易超60亿美元 医药魔方

事件追踪
2021-05-20 映恩生物Duality Biologics完成9000万美元B轮融资

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/250407

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

The seemingly negative pandemic effects and resource/product shortages are encouraging and allowing organizations to innovate and change.The news of cash-rich organizations getting ready for the post-Covid growth economy is a sign of more than capital spending plans. Cash provides a cushion for risk-taking and a tool for growth.

Mr. Durov launched Telegram in late 2013 with his brother, Nikolai, just months before he was pushed out of VK, the Russian social-media platform he founded. Mr. Durov pitched his new app—funded with the proceeds from the VK sale—less as a business than as a way for people to send messages while avoiding government surveillance and censorship.

Readhub from de


Telegram Readhub
FROM USA